Strides Pharma Science advanced 2.68% to Rs 817.90 after its step‐down wholly owned subsidiary, Strides Pharma Global Pte. Singapore received approval from the United States Food & Drug Administration (USFDA) for Gabapentin tablets.
| Subscribe To Our Free Newsletter |
